Changes in Lung Function and Chylous Effusions in Patients With Lymphangioleiomyomatosis Treated With Sirolimus

Por Taveira-DaSilva, Angelo M., Hathaway, Olanda, Stylianou, Mario, Moss, Joel
Publicado em 2011

Joint analysis of case-parents trio and unrelated case-control designs in large scale association studies

Por Joo, Jungnam, Tian, Xin, Zheng, Gang, Stylianou, Mario, Lin, Jing-Ping, Geller, Nancy L
Publicado em 2007

Serum Vascular Endothelial Growth Factor-D Levels in Patients With Lymphangioleiomyomatosis Reflect Lymphatic Involvement

Por Glasgow, Connie G., Avila, Nilo A., Lin, Jing-Ping, Stylianou, Mario P., Moss, Joel
Publicado em 2009

Robust ranks of true associations in genome-wide case-control association studies

Por Zheng, Gang, Joo, Jungnam, Lin, Jing-Ping, Stylianou, Mario, Waclawiw, Myron A, Geller, Nancy L
Publicado em 2007

Retrospective Review of Combined Sirolimus and Simvastatin Therapy in Lymphangioleiomyomatosis

Por Taveira-DaSilva, Angelo M., Jones, Amanda M., Julien-Williams, Patricia A., Stylianou, Mario, Moss, Joel
Publicado no Chest (2015)

Sustained Effects of Sirolimus on Lung Function and Cystic Lung Lesions in Lymphangioleiomyomatosis

Por Yao, Jianhua, Taveira-DaSilva, Angelo M., Jones, Amanda M., Julien-Williams, Patricia, Stylianou, Mario, Moss, Joel
Publicado no Am J Respir Crit Care Med (2014)

ADP-Ribosylarginine Hydrolase Regulates Cell Proliferation and Tumorigenesis

Por Kato, Jiro, Zhu, Jianfeng, Liu, Chengyu, Stylianou, Mario, Hoffmann, Victoria, Lizak, Martin J., Glasgow, Connie G., Moss, Joel
Publicado em 2011

Reversible Airflow Obstruction in Lymphangioleiomyomatosis

Por Taveira-DaSilva, Angelo M., Steagall, Wendy K., Rabel, Antoinette, Hathaway, Olanda, Harari, Sergio, Cassandro, Roberto, Stylianou, Mario, Moss, Joel
Publicado em 2009

Effect of Fasting on the Size of Lymphangioleiomyomas in Patients With Lymphangioleiomyomatosis

Por Taveira-DaSilva, Angelo M., Jones, Amanda M., Julien-Williams, Patricia, Shawker, Thomas, Glasgow, Connie G., Stylianou, Mario, Moss, Joel
Publicado no Chest (2015)

Effects of Prolactin on TSC2-Null Eker Rat Cells and in Pulmonary Lymphangioleiomyomatosis

Por Terasaki, Yasuhiro, Yahiro, Kinnosuke, Pacheco-Rodriguez, Gustavo, Steagall, Wendy K., Stylianou, Mario P., Evans, Jilly F., Walker, Ameae M., Moss, Joel
Publicado em 2010

Sirolimus Decreases Circulating Lymphangioleiomyomatosis Cells in Patients With Lymphangioleiomyomatosis

Por Cai, Xiong, Pacheco-Rodriguez, Gustavo, Haughey, Mary, Samsel, Leigh, Xu, Suowen, Wu, Hai-Ping, McCoy, J. Philip, Stylianou, Mario, Darling, Thomas N., Moss, Joel
Publicado em 2014

Functional Status, Heart Rate, and Rhythm Abnormalities in 521 Fontan Patients 6-18 Years of Age

Por Blaufox, Andrew D., Sleeper, Lynn A., Bradley, David J., Breitbart, Roger E., Hordof, Allan, Kanter, Ronald J., Stephenson, Elizabeth A., Stylianou, Mario, Vetter, Victoria L., Saul, J. Philip
Publicado em 2008

Relationship of Glycemia Control to Lipid and Blood Pressure Lowering and Atherosclerosis: the SANDS Experience

Por Mete, Mihriye, Wilson, Charlton, Lee, Elisa T., Silverman, Angela, Russell, Marie, Stylianou, Mario, Umans, Jason G., Wang, Wenyu, Howard, Wm. J., Ratner, Robert E., Howard, Barbara V., Fleg, Jerome L.
Publicado em 2011

Oral High-Dose Multivitamins and Minerals or Post Myocardial Infarction Patients in TACT

Por Lamas, Gervasio A., Boineau, Robin, Goertz, Christine, Mark, Daniel B., Rosenberg, Yves, Stylianou, Mario, Rozema, Theodore, Nahin, Richard L., Lindblad, Lauren, Lewis, Eldrin F., Drisko, Jeanne, Lee, Kerry L.
Publicado em 2013

Regulation of growth factor receptor degradation by ADP-ribosylation factor domain protein (ARD) 1

Por Meza-Carmen, Victor, Pacheco-Rodriguez, Gustavo, Kang, Gi Soo, Kato, Jiro, Donati, Chiara, Zhang, Chun-Yi, Vichi, Alessandro, Payne, D. Michael, El-Chemaly, Souheil, Stylianou, Mario, Moss, Joel, Vaughan, Martha
Publicado em 2011

EDTA Chelation Therapy Alone and in Combination with Oral High-Dose Multivitamins and Minerals for Coronary Disease: The Factorial Group Results of the Trial to Assess Chelation Th...

Por Lamas, Gervasio A., Boineau, Robin, Goertz, Christine, Mark, Daniel B., Rosenberg, Yves, Stylianou, Mario, Rozema, Theodore, Nahin, Richard L., Chappell, L. Terry, Lindblad, Lauren, Lewis, Eldrin F., Drisko, Jeanne, Lee, Kerry L.
Publicado em 2014

Aberrant SYK kinase signaling is essential for tumorigenesis induced by TSC2 inactivation

Por Cui, Ye, Steagall, Wendy K., Lamattina, Anthony Mark, Pacheco-Rodriguez, Gustavo, Stylianou, Mario, Kidambi, Pranav, Stump, Benjamin, Golzarri, Fernanda, Rosas, Ivan O., Priolo, Carmen, Henske, Elizabeth P., Moss, Joel, El-Chemaly, Souheil
Publicado no Cancer Res (2017)

THE VENTRICULAR VOLUME VARIABILITY STUDY OF THE PEDIATRIC HEART NETWORK: STUDY DESIGN AND IMPACT OF BEAT AVERAGING AND VARIABLE TYPE ON THE REPRODUCIBILITY OF ECHOCARDIOGRAPHIC MEA...

Por Colan, Steven D., Shirali, Girish, Margossian, Renee, Gallagher, Dianne, Altmann, Karen, Canter, Charles, Chen, Shan, Golding, Fraser, Radojewski, Elizabeth, Rychik, Jack, Stylianou, Mario, Tani, Lloyd Y., Tierney, Elif Seda Selamet, Wang, Yanli, Sleeper, Lynn A.
Publicado em 2012

EFFECT OF STATINS ALONE VERSUS STATINS PLUS EZETIMIBE ON CAROTID ATHEROSCLEROSIS IN TYPE 2 DIABETES: THE SANDS TRIAL

Por Fleg, Jerome L., Mete, Mihriye, Howard, Barbara V., Umans, Jason G., Roman, Mary J., E, Robert, Ratner, MD, Silverman, Angela, Galloway, James M., Henderson, Jeffrey A., Weir, Matthew R., Wilson, Charlton, Stylianou, Mario, Howard, Wm. James
Publicado em 2008

Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2

Por Ikeda, Yoshihiko, Taveira-DaSilva, Angelo M., Pacheco-Rodriguez, Gustavo, Steagall, Wendy K., El-Chemaly, Souheil, Gochuico, Bernadette R., May, Rose M., Hathaway, Olanda M., Li, Shaowei, Wang, Ji-an, Darling, Thomas N., Stylianou, Mario, Moss, Joel
Publicado em 2011